cis-p-Coumaroylcorosolic acid



Compound IDCDAMM02016
Common namecis-p-Coumaroylcorosolic acid
IUPAC name11-hydroxy-10-[3-(4-hydroxyphenyl)prop-2-enoyloxy]-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid
Molecular formulaC39H54O6

Experimental data

Retention time11.6
Adduct[M+H]+
Actual mz619.399
Theoretical mz619.399
Error0.61
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.6825

Identifiers and class information

Inchi keyFEVUQLLYZLSRLB-XNTDXEJSNA-N
SmilesO=C(OC1C(O)CC2(C)C3CC=C4C5C(C)C(C)CCC5(C(=O)O)CCC4(C)C3(C)CCC2C1(C)C)C=CC6=CC=C(O)C=C6
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)4
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)618.852
Computed dipole moment(dipole)8.737
Total solvent accessible surface area (SASA)931.454
Hydrophobic component of SASA (FOSA)548.112
Hydrophilic component of SASA (FISA)188.777
Pie component of the SASA (PISA)194.564
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1856.07
Number of hydrogen bond donors (donorHB)3
Number of hydrogen bond acceptors (accptHB)6.45
Free energy of solvation of dipole (dip^2/V)0.0411287
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0119939
Globularity descriptor (glob)0.784152
Predicted polarizability in cubic angstroms (QPpolrz)65.489
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.775
Predicted octanol/gas partition coefficient (QPlogPoct)30.724
Predicted water/gas partition coefficient (QPlogPw)13.771
Predicted octanol/water partition coefficient (QPlogPo/w)7.332
Predicted aqueous solubility (QPlogS)-9.346
Conformation-independent predicted aqueous solubility (CIQPlogS)-9.431
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.145
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)40.675
Predicted brain/blood partition coefficient (QPlogBB)-1.905
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)19.753
Predicted skin permeability, log Kp (QPlogKp)-3.641
PM3 calculated ionization potential (IP(ev))9.182
PM3 calculated electron affinity (EA(eV))0.815
Number of likely metabolic reactions (#metab)4
Prediction of binding to human serum albumin (QPlogKhsa)1.788
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)72.764
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)118.183
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29350PTPN6Protein-tyrosine phosphatase 1CT98264SEA
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SwissTargetPrediction and SEA
P17706PTPN2T-cell protein-tyrosine phosphataseT49156SEA
Q8TDU6GPBAR1G-protein coupled bile acid receptor 1T86273SEA
P06746POLBDNA polymerase beta (by homology)T06958SwissTargetPrediction and SEA
P13726F3Coagulation factor VII/tissue factorT72702SEA
Q08499PDE4DPhosphodiesterase 4DT02001SwissTargetPrediction
O76074PDE5APhosphodiesterase 5AT07663SwissTargetPrediction
P16885PLCG2Phospholipase C-gamma-2T93922SEA
O76083PDE9APhosphodiesterase 9AT17852SwissTargetPrediction
Q01064PDE1BPhosphodiesterase 1BT77613SwissTargetPrediction and SEA
O43826SLC37A4Glucose-6-phosphate translocaseT47306SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T49156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P17706PTPN2
T86273DI0417Type 2 diabetes mellitus[ICD-11: 5A11]Q8TDU6GPBAR1
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T72702DI0075Cervical cancer[ICD-11: 2C77]P13726F3
T02001DI0411Tonus and reflex abnormality[ICD-11: MB47]Q08499PDE4D
T07663DI0190Hypertension[ICD-11: BA00-BA04]O76074PDE5A
T07663DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]O76074PDE5A
T07663DI0378Sexual dysfunction[ICD-11: HA00-HA01]O76074PDE5A
T07663DI0411Tonus and reflex abnormality[ICD-11: MB47]O76074PDE5A
T17852DI0025Alzheimer disease[ICD-11: 8A20]O76083PDE9A
T17852DI0115Dementia[ICD-11: 6D80-6D8Z]O76083PDE9A
T17852DI0165Genitourinary disease[ICD-11: GA0Z-GC8Z]O76083PDE9A
T17852DI0175Heart failure[ICD-11: BD10-BD1Z]O76083PDE9A
T17852DI0256Mental/behavioural/neurodevelopmental disorder[ICD-11: 6E20-6E8Z]O76083PDE9A
T17852DI0331Parkinsonism[ICD-11: 8A00]O76083PDE9A
T17852DI0370Schizophrenia[ICD-11: 6A20]O76083PDE9A
T17852DI0381Sickle-cell disorder[ICD-11: 3A51]O76083PDE9A
T77613DI0265Mild neurocognitive disorder[ICD-11: 6D71]Q01064PDE1B

Copyright © 2025